Phase II study of neoadjuvant therapy with epirubicin and docetaxel for women with locally advanced breast cancer.

被引：0
|
作者：
Holter, JL
Tfayli, A
Venkattapa, S
Bova, A
Howard, O
机构：
[1] Univ Oklahoma, Moore, OK USA
[2] Univ Oklahoma, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：98S / 98S
页数：1
相关论文
共 50 条
  • [31] Activity of combination chemotherapy, docetaxel and epirubicin as neoadjuvant therapy for women with breast cancer
    Tfayli, Arafat
    Holter, Jennifer
    Bova, Abby
    Venkatappa, Siddhartha
    Bullock, Susie
    Dooley, William
    Ozer, Howard
    ANTICANCER RESEARCH, 2006, 26 (6C) : 4911 - 4916
  • [32] Phase I study of docetaxel and epirubicin in advanced breast cancer
    Panagos, G
    Mavroudis, D
    Potamianou, A
    Malamos, N
    Kourousis, C
    Kakolyris, S
    Souglakos, J
    Sarra, E
    Giannakakis, T
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 21 - 21
  • [33] Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer
    Won, Hye Sung
    Kim, Yong Seok
    Kim, Jeong Soo
    Chang, Eun Deok
    Na, Sae Jung
    Whang, In Yong
    Lee, Dong Soo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (06): : 1489 - 1496
  • [34] A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
    Jeon, Ye Won
    Kim, Tae Hyun
    Youn, Hyun Jo
    Han, Sehwan
    Jung, Yongsik
    Gwak, Geumhee
    Park, Young Sam
    Kim, Jeong Soo
    Suh, Young Jin
    JOURNAL OF BREAST CANCER, 2017, 20 (04) : 340 - 346
  • [35] Phase II study of neoadjuvant treatment with docetaxel, doxorubicin and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Khosravi-Shahi, P.
    Mendez, M.
    Quiben, R.
    Palomero, I.
    Izarzugaza, Y.
    Belon, J.
    Garcia-Alfonso, P.
    Perez-Manga, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Perez Manga, Gumersindo
    Khosravi Shahi, Parham
    Mendez Urena, Miguel
    Quiben Pereira, Rosa
    Palomero Plaza, Maria Isabel
    Izarzugaza Peron, Yann
    Gonzalez Del Val, Ricardo
    Belon Carrion, Joaquin
    Perez Canon, Esperanza
    Garcia Alfonso, Pilar
    BREAST CANCER, 2010, 17 (03) : 205 - 211
  • [37] Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Gumersindo Pérez Manga
    Parham Khosravi Shahi
    Miguel Méndez Ureña
    Rosa Quiben Pereira
    María Isabel Palomero Plaza
    Yann Izarzugaza Peron
    Ricardo González Del Val
    Joaquín Belón Carrión
    Esperanza Pérez Cañón
    Pilar García Alfonso
    Breast Cancer, 2010, 17 : 205 - 211
  • [38] Lonidamine plus epirubicin and cyclophosphamide in advanced breast cancer. A phase II study
    Gardin, G
    Barone, C
    Nascimben, O
    Ianniello, G
    Sturba, F
    Contu, A
    Pronzato, P
    Rosso, R
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (01) : 176 - 177
  • [39] Prospective Evaluation of Radiation Pneumonitis in Neoadjuvant Concurrent Docetaxel and Radiation Therapy for Locally Advanced Breast Cancer.
    Louie, A. V.
    Rodrigues, G.
    Sathya, A.
    Perera, F.
    Ong, M.
    D'Souza, D.
    Chambers, A. F.
    Brackstone, M.
    CANCER RESEARCH, 2011, 71
  • [40] Capecitabine in association with epirubicin and docetaxel as a first line treatment in advanced breast cancer. A multicenter phase II study.
    Rosso, R
    Del Mastro, L
    Durando, A
    Garrone, O
    Cherubini, R
    Scotto, T
    Genta, F
    Occelli, M
    Bellino, R
    Bighin, C
    Catzeddu, T
    Stevani, I
    Baldini, A
    Lambiase, A
    Venturini, M
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 270 - 270
12345